Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TFPI' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 134 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kanabrocki, EL; George, M; Hermida, RC; Messmore, HL; Ryan, MD; Ayala, DE; Hoppensteadt, DA; Fareed, J; Bremner, FW; Third, JLHC; Shirazi, P; Nemchausky, BA
      Day-night variations in blood levels of nitric oxide, T-TFPI, and E-selectin

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    2. Cella, G; Sbarai, A; Mazzaro, G; Vanzo, B; Romano, S; Hoppensteadt, D; Fareed, J
      Plasma markers of endothelial dysfunction in chronic obstructive pulmonarydisease

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    3. Cella, G; Sbarai, A; Mazzaro, G; Motta, G; Carraro, P; Andreozzi, GM; Hoppensteadt, DA; Fareed, J
      Tissue factor pathway inhibitor release induced by defibrotide and heparins

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    4. Mori, Y; Wada, H; Okugawa, Y; Tamaki, S; Nakasaki, T; Watanabe, R; Gabazza, EC; Nishikawa, M; Minami, N; Shiku, H
      Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    5. Hakki, SI; Fareed, J; Hoppensteadt, DA; Abdullah, H; Camblin, J; Nasseri, AF; Hamadeh, O; Wright, T
      Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery (vol 6, pg 206, 2000)

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    6. Kojima, T; Gando, S; Kemmotsu, O; Mashio, H; Goda, Y; Kawahigashi, H; Watanabe, N
      Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: Role of tissue factor pathway inhibitor

      JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
    7. Tasiou, A; Konduri, SD; Yanamandra, N; Dinh, DH; Olivero, WC; Gujrati, M; Obeyesekere, M; Rao, JS
      A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas

      INTERNATIONAL JOURNAL OF ONCOLOGY
    8. Konduri, SD; Tasiou, A; Chandrasekar, N; Rao, JS
      Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro

      INTERNATIONAL JOURNAL OF ONCOLOGY
    9. Moatti, D; Meirhaeghe, A; Ollivier, V; Bauters, C; Amouyel, P; de Prost, D
      Polymorphisms of the tissue factor pathway inhibitor gene and the risk of restenosis after coronary angioplasty

      BLOOD COAGULATION & FIBRINOLYSIS
    10. Asakura, H; Ontachi, Y; Mizutani, T; Kato, M; Saito, M; Morishita, E; Yamazaki, M; Suga, Y; Takami, A; Miyamoto, K; Nakao, S
      Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases

      BLOOD COAGULATION & FIBRINOLYSIS
    11. Konduri, SD; Rao, CN; Chandrasekar, N; Tasiou, A; Mohanam, S; Kin, Y; Lakka, SS; Dinh, D; Olivero, WC; Gujrati, M; Foster, DC; Kisiel, W; Rao, JS
      A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion

      ONCOGENE
    12. Akarsu, M; Demirkan, F; Ozsan, GH; Onen, F; Yuksel, F; Ozkan, S; Undar, B
      Increased levels of tissue factor pathway inhibitor may reflect disease activity and play a role in thrombotic tendency in Behcet's disease

      AMERICAN JOURNAL OF HEMATOLOGY
    13. Kereveur, A; Enjyoji, K; Masuda, K; Yutani, C; Kato, H
      Production of tissue factor pathway inhibitor in cardiomyocytes and its upregulation by interleukin-1

      THROMBOSIS AND HAEMOSTASIS
    14. Bajaj, MS; Birktoft, JJ; Steer, SA; Bajaj, SP
      Structure and biology of tissue factor pathway inhibitor

      THROMBOSIS AND HAEMOSTASIS
    15. Brown, JR; Kuter, DJ
      The effect of unfractionated vs. low molecular weight heparin on tissue factor pathway inhibitor levels in hospital inpatients

      THROMBOSIS AND HAEMOSTASIS
    16. Morange, PE; Renucci, JF; Charles, MA; Aillaud, MF; Giraud, F; Grimaux, M; Juhan-Vague, I
      Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers

      THROMBOSIS AND HAEMOSTASIS
    17. Alban, S; Gastpar, R
      Plasma levels of total and free tissue factor pathway inhibitor (TFPI) as individual pharmacological parameters of various heparins

      THROMBOSIS AND HAEMOSTASIS
    18. Li, AG; Chang, ACK; Peer, GT; Wun, TC; Taylor, FB
      Recombinant tissue factor pathway inhibitor enhances the binding of factorXa to human monocytes

      THROMBOSIS AND HAEMOSTASIS
    19. Uszynski, M; Zekanowska, E; Uszynski, W; Kuczynski, J
      Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    20. Kamei, S; Kazama, Y; Kuijper, JL; Foster, DC; Kisiel, W
      Genomic structure and promoter activity of the human tissue factor pathwayinhibitor-2 gene

      BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    21. Alban, S
      Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    22. Gando, S; Nanzaki, S; Morimoto, Y; Ishitani, T; Kemmotsu, O
      Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients

      CRITICAL CARE MEDICINE
    23. Opal, SM; Palardy, JE; Parejo, NA; Creasey, AA
      The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis

      CRITICAL CARE MEDICINE
    24. Astermark, J; Tengborn, L; Hedner, U; Berntorp, E
      Anti- and procoagulant activities in factor VII-deficient subjects

      THROMBOSIS RESEARCH
    25. Bajaj, MS; Tyson, DR; Steer, SA; Kuppuswamy, MN
      Role of GATA motifs in tissue factor pathway inhibitor gene expression in malignant cells

      THROMBOSIS RESEARCH
    26. Masuoka, H; Ito, M; Kamei, S; Ozaki, M; Kawasaki, A; Nakano, T
      Level of plasma tissue factor pathway inhibitor is inversely correlated with intraarterial diastolic pressure in subjects who underwent coronary angiography

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    27. de Reynoso, PT; Remigio, AS
      Severe sepsis and septic shock: crossroad of inflammation and coagulation

      MEDICINA CLINICA
    28. Cella, G; Bellotto, F; Tona, F; Sbarai, A; Mazzaro, G; Motta, G; Fareed, J
      Plasma markers of endothelial dysfunction in pulmonary hypertension

      CHEST
    29. Adams, MJ; Donohoe, S; Mackie, IJ; Machin, SJ
      Anti-tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome

      BRITISH JOURNAL OF HAEMATOLOGY
    30. Amini-Nekoo, A; Futers, TS; Moia, M; Mannucci, PM; Grant, PJ; Ariens, RAS
      Analysis of the tissue factor pathway inhibitor gene and antigen levels inrelation to venous thrombosis

      BRITISH JOURNAL OF HAEMATOLOGY
    31. Moatti, D; Faure, S; Fumeron, F; Amara, ME; Seknadji, P; McDermott, DH; Debre, P; Aumont, MC; Murphy, PM; de Prost, D; Combadiere, C
      Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease

      BLOOD
    32. Faust, SN; Heyderman, RS; Levin, M
      Disseminated intravascular coagulation and purpura fulminans secondary to infection

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    33. Kawaguchi, A; Miyao, Y; Noguchi, T; Nonogi, H; Yamagishi, M; Miyatake, K; Kamikubo, Y; Kumeda, K; Tsushima, M; Yamamoto, A; Kato, H
      Intravascular free tissue factor pathway inhibitor is inversely correlatedwith HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    34. Grabowski, EF; Carter, CA; Tsukurov, O; Conroy, N; Hsu, CY; Abbott, WM; Ingelfinger, JR; Orkin, RW
      Comparison of human umbilical vein and adult saphenous vein endothelial cells: Implications for newborn hemostasis and for laboratory models of endothelial cell function

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    35. Hakki, SI; Fareed, J; Hoppensteadt, DA; Abdullah, H; Camblin, J; Nasseri, AF; Hamadeh, O; Wright, T
      Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    36. Inoue, A; Wada, H; Takagi, M; Yamamuro, M; Mukai, K; Nakasaki, T; Shimura, M; Hiyoyama, K; Deguchi, H; Gabazza, EC; Mori, Y; Nishikawa, M; Deguchi, K; Shiku, H
      Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    37. Bladbjerg, EM; Larsen, LF; Ostergaard, P; Jespersen, J
      In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. Possible implications for measurements in vivo after heparin therapy

      BLOOD COAGULATION & FIBRINOLYSIS
    38. Mukherjee, M; Ranlall, N; Patel, G; Rutlin, A; Jehanli, A; Kakkar, VV
      Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease

      BLOOD COAGULATION & FIBRINOLYSIS
    39. Sun, LB; Utoh, J; Kunitomo, R; Tsurusaki, S; Tagami, H; Hirata, T; Moriyama, S; Okamoto, K; Kitamura, N
      Altered plasma antigen levels of tissue factor pathway inhibitor during open-heart surgery

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    40. Edstrom, CS; Calhoun, DA; Christensen, RD
      Expression of tissue factor pathway inhibitor in human fetal and placentaltissues

      EARLY HUMAN DEVELOPMENT
    41. Okugawa, Y; Wada, H; Noda, T; Sakakura, M; Nakasaki, T; Watanabe, R; Deguchi, H; Gabazza, EC; Mori, Y; Nishikawa, M; Deguchi, K; Nobori, T; Shiku, H
      Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation

      AMERICAN JOURNAL OF HEMATOLOGY
    42. Salemink, I; Blezer, R; Willems, GM; Galli, M; Bevers, E; Lindhout, T
      Antibodies to beta(2)-glycoprotein I associated with antiphospholipid syndrome suppress the inhibitory activity of tissue factor pathway inhibitor

      THROMBOSIS AND HAEMOSTASIS
    43. Rigla, M; Mateo, J; Fontcuberta, J; Souto, JC; de Leiva, A; Perez, A
      Normalisation of tissue factor pathway inhibitor activity after glycaemic control optimisation in type 1 diabetic patients

      THROMBOSIS AND HAEMOSTASIS
    44. Hansen, JB; Svensson, B; Olsen, R; Ezban, M; Osterud, B; Paulssen, RH
      Heparin induces synthesis and secretion of tissue factor pathway inhibitorfrom endothelial cells in vitro

      THROMBOSIS AND HAEMOSTASIS
    45. Konduri, SD; Tasiou, A; Chandrasekar, N; Nicolson, GL; Rao, JS
      Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion

      CLINICAL & EXPERIMENTAL METASTASIS
    46. Lakka, SS; Konduri, SD; Mohanam, S; Nicolson, GL; Rao, JS
      In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2

      CLINICAL & EXPERIMENTAL METASTASIS
    47. Yamamoto, N; Ogawa, H; Oshima, S; Soejima, H; Fujii, H; Misumi, K; Takazoe, K; Mizuno, Y; Noda, K; Saito, T; Tsuji, I; Kumeda, K; Nakamura, S; Yasue, H
      The effect of heparin on tissue factor and tissue factor pathway inhibitorin patients with acute myocardial infarction

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    48. Bilsel, AS; Onaran, N; Moini, H; Emerk, K
      Long-term effect of 17 beta-estradiol and thrombin on tissue factor pathway inhibitor release from HUVEC

      THROMBOSIS RESEARCH
    49. Cella, G; Burlina, A; Sbarai, A; Motta, G; Girolami, A; Berrettini, M; Strauss, W
      Tissue factor pathway inhibitor levels in patients with homocystinuria

      THROMBOSIS RESEARCH
    50. Bendz, B; Andersen, TO; Sandset, PM
      A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1

      THROMBOSIS RESEARCH
    51. Hansen, JB; Svensson, B; Sandset, PM; Thijssen, F
      Reduction of factor FVIIa activity during heparin therapy evidence for assay interactions with tissue factor pathway inhibitor and antithrombin

      THROMBOSIS RESEARCH
    52. Hansen, JB; Naalsund, T; Sandset, PM; Svensson, B
      Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin

      THROMBOSIS RESEARCH
    53. Shimokawa, T; Yamamoto, K; Kojima, T; Saito, H
      Down-regulation of murine tissue factor pathway inhibitor mRNA by endotoxin and tumor necrosis factor-alpha in vitro and in vivo

      THROMBOSIS RESEARCH
    54. Rao, CN; Reddy, P; Reeder, DJ; Liu, YY; Stack, SM; Kisiel, W; Woodley, DT
      Prokaryotic expression, purification, and reconstitution of biological activities (antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    55. Chouhan, VD; Comerota, AJ; Sun, L; Hada, R; Gaughan, JP; Rao, AK
      Inhibition of tissue factor pathway during intermittent pneumatic compression - A possible mechanism for antithrombotic effect

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    56. Ohkura, N; Seo, G; Kohno, I; Kumeda, K; Wada, H; Kamikubo, Y; Shiku, H; Kato, H
      Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xacomplex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascularcoagulation

      BLOOD COAGULATION & FIBRINOLYSIS
    57. Saito, Y; Wada, H; Yamamuro, M; Inoue, A; Shimura, M; Hiyoyama, K; Gabazza, EC; Isaka, N; Shiku, H; Takeya, H; Suzuki, K; Kumeda, K; Kato, H; Nakano, T
      Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease

      AMERICAN JOURNAL OF HEMATOLOGY
    58. Shimura, M; Wada, H; Nakasaki, T; Hiyoyama, K; Mori, Y; Nishikawa, M; Deguchi, H; Deguchi, K; Gabazza, EC; Shiku, H
      Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

      AMERICAN JOURNAL OF HEMATOLOGY
    59. Bajaj, MS; Tricomi, SM
      Plasma levels of the three endothelial-specific proteins von Willebrand factor, tissue factor pathway inhibitor, and thrombomodulin do not predict the development of acute respiratory distress syndrome

      INTENSIVE CARE MEDICINE
    60. Mukherjee, M; Kakkar, VV
      Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor

      THROMBOSIS AND HAEMOSTASIS
    61. Lupu, C; Kruithof, EKO; Kakkar, VV; Lupu, F
      Acute release of tissue factor pathway inhibitor after in vivo thrombin generation in baboons

      THROMBOSIS AND HAEMOSTASIS
    62. Bajaj, MS; Steer, S; Kuppuswamy, MN; Kisiel, W; Bajaj, SP
      Synthesis and expression of tissue factor pathway inhibitor by serum-stimulated fibroblasts, vascular smooth muscle cells and cardiac myocytes

      THROMBOSIS AND HAEMOSTASIS
    63. Ariens, RAS; Alberio, G; Moia, M; Mannucci, PM
      Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis

      THROMBOSIS AND HAEMOSTASIS
    64. Gando, S; Nanzaki, S; Morimoto, Y; Kobayashi, S; Kemmotsu, O
      Tissue factor and tissue factor pathway inhibitor levels during and after cardiopulmonary resuscitation

      THROMBOSIS RESEARCH
    65. Sato, Y; Kataoka, H; Asada, Y; Marutsuka, K; Kamikubo, Y; Koono, M; Sumiyoshi, A
      Overexpression of tissue factor pathway inhibitor in aortic smooth muscle cells inhibits cell migration induced by tissue factor factor VIIa complex

      THROMBOSIS RESEARCH
    66. Soejima, H; Ogawa, H; Yasue, H; Nishiyama, K; Kaikita, K; Misumi, K; Takazoe, K; Kugiyama, K; Tsuji, I; Kumeda, K; Nakamura, S
      Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris

      THROMBOSIS RESEARCH
    67. Grabowski, EF; Carter, CA; Ingelfinger, JR; Tsukurov, O; Conroy, N; Abbott, WM; Orkin, RW
      Comparison of tissue factor pathway in human umbilical vein and adult saphenous vein endothelial cells: Implications for newborn hemostasis and for laboratory models of endothelial cell function

      PEDIATRIC RESEARCH
    68. Hine, C; Enjyoji, K; Kokame, K; Nakamura, S; Takei, A; Kamikubo, Y; Sueishi, K; Kato, H
      Monkey hepatocytes efficiently express tissue factor pathway inhibitor (TFPI), in contrast with human and rat hepatocytes

      JOURNAL OF BIOCHEMISTRY
    69. Badimon, JJ; Lettino, M; Toschi, V; Fuster, V; Berrozpe, M; Chesebro, JH; Badimon, L
      Local inhibition of tissue factor reduces the thrombogenicity of disruptedhuman atherosclerotic plaques - Effects of tissue factor pathway inhibitoron plaque thrombogenicity under flow conditions

      CIRCULATION
    70. Bendz, B; Hansen, JB; Andersen, TO; Ostergaard, P; Sandset, PM
      Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins

      BRITISH JOURNAL OF HAEMATOLOGY
    71. WUN TC; PALMIER MO
      HEPARIN-TISSUE FACTOR PATHWAY INHIBITOR COMPLEXES - ANTICOAGULANT ANDPHARMACOKINETIC PROPERTIES

      Clinical and applied thrombosis/hemostasis
    72. KLAUSER RJ; HOPPENSTEADT D; FAREED J
      TISSUE FACTOR PATHWAY INHIBITOR IS A POTENT INHIBITOR OF PLASMIN

      Clinical and applied thrombosis/hemostasis
    73. BRIDEY F; LACOMBE C; SUSTENDAL L; MOATTI D; COMBE F; MAMMES O; DEPROST D
      DEVELOPMENT OF A METHOD TO SEPARATE LIPOPROTEIN-BOUND AND LIPOPROTEIN-DEPLETED TISSUE FACTOR PATHWAY INHIBITOR - MEASUREMENT OF FREE TISSUEFACTOR PATHWAY INHIBITOR ACTIVITY

      Blood coagulation & fibrinolysis
    74. YAMAMURO M; WADA H; KUMEDA K; INOUE A; TSUJI I; NAKASAKI T; SHIMURA M; HIYOYAMA K; GABAZZA EC; NISHIKAWA M; DEGUCHI K; SHIKU H; KATO H
      CHANGES IN PLASMA TISSUE FACTOR PATHWAY INHIBITOR LEVELS DURING THE CLINICAL COURSE OF DISSEMINATED INTRAVASCULAR COAGULATION

      Blood coagulation & fibrinolysis
    75. KAISER B; GLUSA E; HOPPENSTEADT DA; BREDDIN HK; AMIRAL J; FAREED J
      A SUPERSULFATED LOW-MOLECULAR-WEIGHT HEPARIN (IK-SSH) INCREASES PLASMA-LEVELS OF FREE AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION IN HUMANS

      Blood coagulation & fibrinolysis
    76. FALKON L; GARI M; BARBANOJ M; AMIRAL J; FONTCUBERTA J
      TISSUE FACTOR PATHWAY INHIBITOR AND ANTI-FXA KINETIC PROFILES OF A NEW LOW-MOLECULAR-MASS HEPARIN, BEMIPARIN, AT THERAPEUTIC SUBCUTANEOUS DOSES

      Blood coagulation & fibrinolysis
    77. BROZE GJ
      TISSUE FACTOR PATHWAY INHIBITOR GENE DISRUPTION

      Blood coagulation & fibrinolysis
    78. Yorioka, N; Taniguchi, Y; Yamashita, K; Ueda, C; Nakamura, C; Harada, S; Yamakido, M
      Tissue factor and tissue factor pathway inhibitor in hemodialysis patients

      INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    79. GIRAUX JL; TAPONBRETAUDIERE J; MATOU S; FISCHER AM
      FUCOIDAN, AS HEPARIN, INDUCES TISSUE FACTOR PATHWAY INHIBITOR RELEASEFROM CULTURED HUMAN ENDOTHELIAL-CELLS

      Thrombosis and haemostasis
    80. MORISHITA E; HASHIMOTO T; ASAKURA H; SAITO M; YAMAZAKI M; AOSHIMA K; YOSHIDA T; KATO H; MATSUDA T
      INCREASED PLASMA-LEVELS OF FREE TISSUE FACTOR PATHWAY INHIBITOR IN PATIENTS WITH GRAVES-DISEASE

      Thrombosis and haemostasis
    81. IDELL S; PENDURTHI U; PUEBLITZ S; KOENIG K; WILLIAMS T; RAO LVM
      TISSUE FACTOR PATHWAY INHIBITOR IN TETRACYCLINE-INDUCED PLEURITIS IN RABBITS

      Thrombosis and haemostasis
    82. Altman, R; Scazziota, A; Rouvier, J
      Efficacy of unfractionated heparin, low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitor

      HAEMOSTASIS
    83. HANSEN JB; SANDSET PM
      DIFFERENTIAL-EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN AND UNFRACTIONATED HEPARIN ON CIRCULATING LEVELS OF ANTITHROMBIN AND TISSUE FACTOR PATHWAY INHIBITOR (TFPI) - A POSSIBLE MECHANISM FOR DIFFERENCE IN THERAPEUTIC EFFICACY

      Thrombosis research
    84. KAMIKUBO Y; HAMURO T; TAKEMOTO S; NAKAHARA Y; KAMEI S; NAKAGAKI T; MIYAMOTO S; FUNATSU A; KATO H
      A KINETIC-ANALYSIS OF THE INTERACTION OF HUMAN RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA UTILIZING AN IMMUNOASSAY AND THE EFFECT OF ANTITHROMBIN-III HEPARIN ON THE COMPLEX-FORMATION

      Thrombosis research
    85. IVERSEN N; LINDAHL AK; ABILDGAARD U
      ELEVATED TFPI IN MALIGNANT DISEASE - RELATION TO CANCER TYPE AND HYPERCOAGULATION

      British Journal of Haematology
    86. HANSEN JB; SANDSET PM; HUSEBY KR; HUSEBY NE; BENDZ B
      DIFFERENTIAL EFFECT OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN ON INTRAVASCULAR TISSUE FACTOR PATHWAY INHIBITOR - EVIDENCE FOR A DIFFERENCE IN ANTITHROMBOTIC ACTION

      British Journal of Haematology
    87. GOUINTHIBAULT I; ARKAM R; OFOSU FA; SAMAMA MM
      PREOPERATIVE FACTOR XA-TFPI AND POSTOPERATIVE VENOUS THROMBOSIS

      British Journal of Haematology
    88. YAMAZUMI K; OJIRO M; OKUMURA H; AIKOU T
      AN ACTIVATED STATE OF BLOOD-COAGULATION AND FIBRINOLYSIS IN PATIENTS WITH ABDOMINAL AORTIC-ANEURYSM

      The American journal of surgery
    89. TIEMANN C; PROHASKA W; KORFER R; KORNER M; BRINKMANN T; KLEESIEK K
      EFFECT OF CYCLOSPORINE-A ON THE RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR FROM ENDOTHELIAL-CELLS IN HEART-TRANSPLANT PATIENTS AND CELL-CULTURE

      European journal of clinical chemistry and clinical biochemistry
    90. COLBURN P; KOBAYASHI E; BUONASSISI V
      HEPARAN SULFATE-BINDING PEPTIDE PROMOTES THE DEPOSITION OF PROTEOGLYCANS IN THE EXTRACELLULAR-MATRIX

      Journal of cellular biochemistry
    91. SHIMURA M; WADA H; WAKITA Y; NAKASE T; HIYOYAMA K; NAGAYA S; MORI Y; SHIKU H
      PLASMA TISSUE FACTOR AND TISSUE FACTOR PATHWAY INHIBITOR LEVELS IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION

      American journal of hematology
    92. KAMIKURA Y; WADA H; YAMADA A; SHIMURA M; HIYOYAMA K; SHIKU H; TANIGAWA M; NISHIKAWA H; YAMADA N; ISAKA N; NAKANO T; KUMEDA K; KATO H
      INCREASED TISSUE FACTOR PATHWAY INHIBITOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      American journal of hematology
    93. TROY S; FRUNCILLO R; OZAWA T; MAMMEN E; HOLLOWAY S; CHIANG S
      ABSOLUTE AND COMPARATIVE SUBCUTANEOUS BIOAVAILABILITY OF ARDEPARIN SODIUM, A LOW-MOLECULAR-WEIGHT HEPARIN

      Thrombosis and haemostasis
    94. YONEDA T; KOMOOKA H; UMEYAMA H
      A COMPUTER MODELING STUDY OF THE INTERACTION BETWEEN TISSUE FACTOR PATHWAY INHIBITOR AND BLOOD-COAGULATION FACTOR XA

      Journal of protein chemistry
    95. OSTERGAARD PB; BECK TC; ORSTED H; SVENDSEN A; NORDFANG O; SANDSET PM; HANSEN JB
      AN ENZYME-LINKED IMMUNOSORPTION ASSAY FOR TISSUE FACTOR PATHWAY INHIBITOR

      Thrombosis research
    96. HOLST J; LINDBLAD B; BERGQVIST D; HEDNER U; NORDFANG O; OSTERGAARD P
      THE EFFECT OF PROTAMINE SULFATE ON PLASMA TISSUE FACTOR PATHWAY INHIBITOR RELEASED BY INTRAVENOUS AND SUBCUTANEOUS UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN IN MAN

      Thrombosis research
    97. YAMANOBE F; MOCHIDA S; OHNO A; ISHIKAWA K; FUJIWARA K
      RECOMBINANT HUMAN TISSUE FACTOR PATHWAY INHIBITOR AS A POSSIBLE ANTICOAGULANT TARGETING HEPATIC SINUSOIDAL WALLS

      Thrombosis research
    98. HANSEN JB; HUSEBY KR; HUSEBY NE; EZBAN M; NORDOY A
      TISSUE FACTOR PATHWAY INHIBITOR IN COMPLEX WITH LOW-DENSITY-LIPOPROTEIN ISOLATED FROM HUMAN PLASMA DOES NOT POSSESS ANTICOAGULANT FUNCTION IN TISSUE FACTOR-INDUCED COAGULATION IN-VITRO

      Thrombosis research
    99. DREW AF; DAVENPORT P; APOSTOLOPOULOS J; TIPPING PG
      TISSUE FACTOR PATHWAY INHIBITOR EXPRESSION IN ATHEROSCLEROSIS

      Laboratory investigation
    100. ORTEGO J; ESCRIBANO J; COCAPRADOS M
      GENE-EXPRESSION OF PROTEASES AND PROTEASE INHIBITORS IN THE HUMAN CILIARY EPITHELIUM AND ODM-2 CELLS

      Experimental Eye Research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 03:53:03